Amicus Therapeutics (FOLD) Financials
$14.49
$0.00 (0.00%)As on 27-Apr-2026 09:30EDT
Market cap
$4,550 Mln
Revenue (TTM)
$634 Mln
P/E Ratio
--
P/B Ratio
16.6
Div. Yield
0 %
Income Statement ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
634.21
|
528.30
|
399.36
|
329.23
|
305.51
|
260.89
|
|
|
|
|
|
|
Cost of Revenue
|
80.39
|
52.94
|
37.33
|
38.60
|
34.47
|
31.04
|
|
|
|
|
|
|
Gross Profit
|
553.82
|
475.35
|
362.03
|
290.63
|
271.05
|
229.84
|
|
|
|
|
|
|
Operating Expenses
|
519.33
|
450.48
|
439.24
|
502.75
|
477.48
|
476.84
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
34.49
|
24.88
|
-77.21
|
-212.12
|
-206.43
|
-247.00
|
|
|
|
|
|
|
Other Income
|
--
|
--
|
--
|
7.20
|
-2.65
|
-4.83
|
|
|
|
|
|
|
Profit before Tax
|
0.19
|
-28.76
|
-150.10
|
-242.04
|
-241.55
|
-274.25
|
|
|
|
|
|
|
Provision for Tax
|
27.30
|
27.35
|
1.48
|
-5.47
|
8.91
|
2.60
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
-27.11
|
-56.11
|
-151.58
|
-236.57
|
-250.46
|
-276.85
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
--
|
--
|
--
|
-236.57
|
-250.46
|
-276.85
|
|
|
|
|
|
Liabilities ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
274.24
|
194.05
|
160.17
|
123.05
|
307.37
|
286.38
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
437.80
|
442.29
|
450.02
|
462.10
|
451.80
|
470.46
|
|
|
|
|
|
|
Current Liabilities
|
237.83
|
148.70
|
167.69
|
139.02
|
145.98
|
129.68
|
|
|
|
|
|
|
Total Liabilities
|
949.87
|
785.03
|
777.88
|
724.17
|
905.14
|
886.52
|
|
|
|
|
|
Assets ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
273.70
|
280.30
|
294.82
|
300.35
|
308.31
|
307.05
|
|
|
|
|
|
|
Current Assets
|
676.17
|
504.74
|
483.06
|
423.82
|
596.83
|
579.47
|
|
|
|
|
|
|
Total Assets
|
949.87
|
785.03
|
777.88
|
724.17
|
905.14
|
886.52
|
|
|
|
|
|
|
Total Debt*
|
483.33
|
443.64
|
445.06
|
452.12
|
440.13
|
441.73
|
|
|
|
|
|
|
Net Current Assets
|
438.35
|
356.03
|
315.37
|
284.80
|
450.86
|
449.79
|
|
|
|
|
|
Cashflow ($ Mln) |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
33.15
|
-33.89
|
-69.09
|
-166.58
|
-202.49
|
-233.29
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
-46.43
|
-0.56
|
98.06
|
92.32
|
78.76
|
-13.58
|
|
|
|
|
|
|
Cash from Financing Activities
|
0.61
|
5.12
|
61.68
|
-7.46
|
212.07
|
262.86
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
-81.72
|
88.34
|
15.99
|
|
|
|
|
|
Financials Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-0.09
|
-0.19
|
-0.52
|
-0.84
|
-0.90
|
-1.06
|
|
|
|
|
|
|
Cash EPS ($)
|
-0.06
|
-0.16
|
-0.49
|
-0.82
|
-0.88
|
-1.02
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
0.87
|
0.65
|
0.55
|
0.44
|
1.10
|
1.09
|
|
|
|
|
|
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
0.11
|
-0.11
|
-0.24
|
-0.59
|
-0.73
|
-0.89
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
0.09
|
-0.13
|
-0.26
|
-0.61
|
-0.74
|
-0.90
|
|
|
|
|
|
Profitability Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
-3.89
|
-9.03
|
-25.68
|
-35.77
|
-33.95
|
-39.14
|
|
|
|
|
|
|
ROE (%)
|
-11.58
|
-31.68
|
-107.04
|
-109.93
|
-84.37
|
-72.59
|
|
|
|
|
|
|
ROA (%)
|
-3.13
|
-7.18
|
-20.18
|
-29.04
|
-27.96
|
-31.88
|
|
|
|
|
|
|
EBIT Margin (%)
|
7.31
|
3.95
|
-25.03
|
-62.24
|
-68.44
|
-96.53
|
|
|
|
|
|
|
Net Margin (%)
|
-4.27
|
-10.62
|
-37.96
|
-70.32
|
-82.70
|
-108.12
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.20
|
0.32
|
0.21
|
0.08
|
0.17
|
0.43
|
|
|
|
|
|
|
EBIT Growth (%)
|
122.39
|
120.85
|
51.22
|
1.99
|
16.97
|
25.28
|
|
|
|
|
|
|
Net Profit Growth (%)
|
51.68
|
62.99
|
35.92
|
5.55
|
9.53
|
22.32
|
|
|
|
|
|
|
EPS Growth (%)
|
0.54
|
0.64
|
0.39
|
0.06
|
0.15
|
0.24
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-165.12
|
-50.21
|
-27.48
|
-14.51
|
-12.86
|
-21.86
|
|
|
|
|
|
|
Price / Book Value
|
16.32
|
14.52
|
26.01
|
27.89
|
10.48
|
21.13
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
86.72
|
102.44
|
-46.97
|
-17.99
|
-15.67
|
-24.73
|
|
|
|
|
|
|
Close Price ($)
|
14.24
|
9.42
|
14.19
|
12.21
|
11.55
|
23.09
|
|
|
|
|
|
|
High Price ($)
|
14.36
|
14.53
|
14.57
|
12.96
|
24.84
|
25.39
|
|
|
|
|
|
|
Low Price ($)
|
5.51
|
9.02
|
9.70
|
5.91
|
8.60
|
6.25
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
1.76
|
2.29
|
2.78
|
3.67
|
1.43
|
1.54
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.03
|
0.04
|
0.05
|
0.07
|
0.02
|
0.02
|
|
|
|
|
|
|
Current Ratio
|
2.84
|
3.39
|
2.88
|
3.05
|
4.09
|
4.47
|
|
|
|
|
|
|
Quick Ratio
|
1.88
|
2.60
|
2.52
|
2.88
|
3.90
|
4.32
|
|
|
|
|
|
|
Interest Coverage
|
1.00
|
0.42
|
-1.99
|
-5.52
|
-6.44
|
-11.23
|
|
|
|
|
|
Operating Efficiency Ratios |
Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.18
|
19.14
|
21.94
|
20.11
|
17.24
|
17.99
|
|
|
|
|
|
|
Asset Turnover
|
0.73
|
0.68
|
0.53
|
0.40
|
0.34
|
0.30
|
|
|
|
|
|
|
Receivable days
|
62.32
|
65.24
|
70.35
|
65.94
|
59.53
|
56.15
|
|
|
|
|
|
|
Inventory Days
|
789.67
|
615.65
|
408.60
|
239.57
|
245.72
|
197.64
|
|
|
|
|
|
|
Payable days
|
94.45
|
96.82
|
149.39
|
174.71
|
204.40
|
228.16
|
|
|
|
|
|
|
Cash Conversion Cycle
|
757.53
|
584.08
|
329.56
|
130.79
|
100.85
|
25.63
|
|
|
|
|
|
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
